£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

Alzheimer's Treatment Outlook 2023-2028 - US Market Study

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 23 days · 23 data points (no recent data)

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 12 August 2026 17 August 2026 23 August 2026 28 August 2026 03 September 2026
View at Amazon ↗

Price data last checked 68 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 23 days • 1 price levels

Days at Price
23 days 0 6 12 17 23 £520 Days at Price

Price Analysis

Most common price: £520 (23 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 23 days

Description

This comprehensive market study provides a detailed outlook for Alzheimer's treatments in the United States from 2023 to 2028. Utilizing an econometric model, the research analyzes latent demand across approximately 12,600 cities. The report presents potential industry earnings (P.I.E.) in millions of U.S. dollars to help professionals understand market scale. By providing the percent share of each city relative to its state and the entire country, this data offers comparative benchmarks for effective decision-making. This statistical approach assists in developing precise distribution and sales force strategies based on localized demand patterns.

Key Features

Analyzes latent demand for Alzheimer's treatments across 12,600 cities in the United States.

Provides potential industry earnings (P.I.E.) estimates in millions of U.S. dollars.

Includes comparative benchmarks showing each city's percent share of its state and the nation.

Uses an econometric model to generate statistical data for market analysis.

Supports the development of optimized distribution and sales force strategies.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
09 November 2022

Similar Products You Might Like

Antidepressant and Anti-Anxiety Drug Outlook 2023-2028
97% match

Antidepressant and Anti-Anxiety Drug Outlook 2023-2028

£490.00 03 Sep 2026
The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in China
97% match

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in China

£495.00 05 Sep 2026
The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in Japan
97% match

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in Japan

£495.00 03 Sep 2026
The 2025-2030 World Outlook for Peripheral Neuropathy Treatments
97% match

The 2025-2030 World Outlook for Peripheral Neuropathy Treatments

Price unavailable
Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)
96% match

Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)

Humana

£81.54 30 Sep 2026
Developing Therapeutics for Alzheimer's Disease: Progress and Challenges
96% match

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges

Elsevier

£114.89 11 Sep 2026
Alzheimer's Disease Drug Development: Research and Development Ecosystem
96% match

Alzheimer's Disease Drug Development: Research and Development Ecosystem

Cambridge University Press

£45.44 28 Aug 2026
Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics
95% match

Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics

Springer

£83.20 18 Sep 2026
CRC Press Alzheimer's Disease Computational and Experimental Book
95% match

CRC Press Alzheimer's Disease Computational and Experimental Book

CRC Press

£126.03 06 Nov 2026
The 2023-2028 Outlook for Nocturia Drugs in China
95% match

The 2023-2028 Outlook for Nocturia Drugs in China

£495.00 02 Sep 2026
Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease
95% match

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease

Elsevier

£91.28 11 Sep 2026
Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)
95% match

Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)

Humana

£136.22 06 Nov 2026
The 2023 Report on Pharma Contract Sales: World Market Segmentation by City
95% match

The 2023 Report on Pharma Contract Sales: World Market Segmentation by City

£795.00 05 Nov 2026
Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)
95% match

Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)

Humana

£69.07 12 Sep 2026
Springer Progress in Alzheimer's and Parkinson's Diseases 49
95% match

Springer Progress in Alzheimer's and Parkinson's Diseases 49

Springer

£84.97 18 Sep 2026
The 2023-2028 Outlook for Drug Delivery Products for US Zip Codes
95% match

The 2023-2028 Outlook for Drug Delivery Products for US Zip Codes

£490.00 19 Sep 2026
Brain Imaging: Volume 165 (Progress in Molecular Biology and Translational Science, Volume 165)
95% match

Brain Imaging: Volume 165 (Progress in Molecular Biology and Translational Science, Volume 165)

Elsevier

£128.99 25 Sep 2026
Advances in Neuropharmacology: Drugs and Therapeutics
95% match

Advances in Neuropharmacology: Drugs and Therapeutics

CRC Press

£77.00 26 Sep 2026
Smart Diagnostics for Neurodegenerative Disorders: Neuro-sensors
95% match

Smart Diagnostics for Neurodegenerative Disorders: Neuro-sensors

Elsevier

£106.99 26 Sep 2026
Neuroprotection in Alzheimer's Disease
95% match

Neuroprotection in Alzheimer's Disease

Elsevier

£90.99 25 Sep 2026
Translational Neuropsychopharmacology: 28 (Current Topics in Behavioral Neurosciences, 28)
95% match

Translational Neuropsychopharmacology: 28 (Current Topics in Behavioral Neurosciences, 28)

Springer

£109.64 01 Oct 2026
Systems Biology of Alzheimer's Disease: 1303 (Methods in Molecular Biology, 1303)
95% match

Systems Biology of Alzheimer's Disease: 1303 (Methods in Molecular Biology, 1303)

Humana

£91.80 01 Oct 2026
Premature Ejaculation Treatment Outlook 2023-2028 Study
95% match

Premature Ejaculation Treatment Outlook 2023-2028 Study

£490.00 02 Sep 2026
The 2026-2031 World Outlook for High Potency APIs (HPAPIs)
95% match

The 2026-2031 World Outlook for High Potency APIs (HPAPIs)

£885.00 08 Nov 2026